2010
DOI: 10.1245/s10434-010-1120-2
|View full text |Cite
|
Sign up to set email alerts
|

Sentinel Lymph Node Biopsy in Patients with Previous Ipsilateral Complete Axillary Lymph Node Dissection

Abstract: Reoperative SLN mapping and biopsy is feasible in the setting of local recurrence after previous CALND. This procedure performed for breast cancer recurrence provides important staging information while identifying extra-axillary drainage that could affect both staging and local control.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
17
1
3

Year Published

2011
2011
2021
2021

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 45 publications
(22 citation statements)
references
References 18 publications
1
17
1
3
Order By: Relevance
“…Sentinel node biopsy in patients undergoing postoperative axillary surgery has been described in several articles [41][45]. In 11 (8%) of 135 patients who underwent reoperative sentinel node biopsy with successful mapping, the sentinel node was the contralateral axillary lymph node, and in 6 patients (4%), the ipsilateral clavicular node was the sentinel node.…”
Section: Discussionmentioning
confidence: 99%
“…Sentinel node biopsy in patients undergoing postoperative axillary surgery has been described in several articles [41][45]. In 11 (8%) of 135 patients who underwent reoperative sentinel node biopsy with successful mapping, the sentinel node was the contralateral axillary lymph node, and in 6 patients (4%), the ipsilateral clavicular node was the sentinel node.…”
Section: Discussionmentioning
confidence: 99%
“…Van Wely et al [13] also did not meet the PICO question since they published a mini review showing the association between lower rates of local recurrence and external beam radiation after negative sentinel lymph node detection. Kaur et al [14] reported that remapping of lymph nodes after prior completion of axillary lymph node dissection is feasible and should be considered regardless of the number of initially removed lymph nodes. Although these results are interesting for the management of recurrent disease, they still do not answer our question concerning a comparison of the treatment options in LNRD.…”
Section: Resultsmentioning
confidence: 99%
“…Grundsätzlich kann auch nach BET und vorangegangener Radiotherapie der Brust beim intramammären Rezidiv eine erneute Sentinel-Lymphknotenbiopsie (SLNB) empfohlen und durchgeführt werden [17]. Dabei ist zu beachten, dass bei einer Re-SLNB nach primär erfolgter SLNB eine geringere Detektionsrate zu erwarten ist [18].…”
Section: Frage 3: Sollte Bei Einem Lokalrezidiv In Der Brust Und Aktuunclassified